{
    "clinical_study": {
        "@rank": "8305", 
        "brief_summary": {
            "textblock": "Epidemiologic and retrospective multicenter registry of all patients diagnosed with de novo\n      or secondary AML in the PETHEMA Group institutions. This study is a non-interventional\n      research regarding diagnosis and therapeutic approach"
        }, 
        "brief_title": "Epidemiologic Registry PETHEMA LMA 2013", 
        "completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "AML", 
        "detailed_description": {
            "textblock": "To perform this registry, every patient diagnosed with AML in the participant institutions,\n      regardless type of AML and treatment administered, must be reported. It will be required to\n      registry the main characteristics of the patients and AML at diagnosis, as cytomorphologic,\n      immunophenotypic, and cytogenetic results, according to the habitual practice of the\n      centers. The treatment which has been administered by every center of the PETHEMA Group,\n      even when it is considered as supportive care, and evolution of the disease will also be\n      reported (relapse o death). PETHEMA Group will input all the reported information in data\n      bases with the appropriate security."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Patients diagnosed with acute myeloid leukemia\n\n        Exclusion Criteria:\n\n        no exclusion criteria"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients diagnosed with acute myeloid leukemia"
            }
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02006004", 
            "org_study_id": "PETHEMA LMA 2013"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "AML", 
        "lastchanged_date": "December 4, 2013", 
        "location": {
            "contact": {
                "email": "montesinos_pau@gva.es", 
                "last_name": "Pau Montesinos, Dr"
            }, 
            "facility": {
                "address": {
                    "city": "Valencia", 
                    "country": "Spain"
                }, 
                "name": "Hospital La Fe"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_groups": "1", 
        "official_title": "Epidemiologic Registry of Patients Diagnosed With Acute Myeloid Leukemia (PETHEMA LMA 2013)", 
        "overall_contact": {
            "email": "montesinos_pau@gva.es", 
            "last_name": "Pau Montesinos, Dr", 
            "phone": "+34 96 1244000", 
            "phone_ext": "412394"
        }, 
        "overall_contact_backup": {
            "email": "martinez_davcua@gva.es", 
            "last_name": "David Martinez, Dr", 
            "phone": "+34 96 1244000", 
            "phone_ext": "412394"
        }, 
        "overall_official": {
            "affiliation": "Hospital La Fe", 
            "last_name": "Sanz Miguel Angel, DR", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Spain: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To realize an epidemiologic and retrospective study to assess the characteristics of the patients diagnosed with AML and their disease, regardless the age or treatment", 
            "measure": "Characteristics of the patients diagnosed with AML", 
            "safety_issue": "No", 
            "time_frame": "3 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02006004"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "To correlate clinical and biological features with outcome and evolution of the patients.", 
                "measure": "Prognosis factors", 
                "safety_issue": "No", 
                "time_frame": "3 years"
            }, 
            {
                "description": "To identify and confirm the risk factors which are involved in the evolution of the disease.", 
                "measure": "Risk factors", 
                "safety_issue": "No", 
                "time_frame": "3 years"
            }
        ], 
        "source": "PETHEMA Foundation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "PETHEMA Foundation", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}